What Novugen Pharma does

Novugen Pharma is a privately held pharmaceutical company founded in 2015 and headquartered in Shah Alam, Malaysia, engaged in the manufacturing and distribution of generic medicines and pharmaceutical products. The firm operates with 501-1000 employees, indicating it has reached mid-scale manufacturing and distribution capability rather than remaining an early-stage venture. Its core activity is generic pharma production and channel distribution, serving healthcare providers and downstream customers through its manufacturing and supply-chain infrastructure.

The available source material also situates Novugen within the broader sarcoma drugs market, which the referenced market report sized at $1.37 billion in 2024 with a projection to $2.14 billion by 2029. Within this context, Novugen is described as developing oral therapies and innovative drug formulations for soft tissue sarcoma, targeting hospitals, oncology centers, and healthcare providers. This suggests an oncology-adjacent product line or segment focus layered on top of the firm's generic manufacturing base.

The company's business model centers on pharmaceutical manufacturing and distribution revenue. No specific pricing models, named distribution partners, named customers, named products, or disclosed financials were available in the source material, and no funding rounds, M&A activity, or management team details were documented. The website at novugen.com was observed to return an active verification page, suggesting the company remains operational but offering no further disclosure.

Name

Novugen Pharma

Website

https://novugen.com

Company type

Private

Founded year

2015

Headcount range

501–1,000 employees

Short description

Novugen Pharma is a privately held Malaysian pharmaceutical company, founded in 2015 and based in Shah Alam, that manufactures and distributes generic medicines and pharmaceutical products, with a referenced focus on oral therapies for soft tissue sarcoma.

Ownership category

akta.pro rank

Headquarters

HQ city

Shah Alam

HQ country

Malaysia

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Core offering

Novugen Pharma is a pharmaceutical company engaged in the manufacturing and distribution of generic medicine and pharma products. The company operates as a vertically integrated generic drug producer and distributor, with formulation capabilities targeting oral solid-dosage formats. According to one third-party source, its development activities also encompass innovative drug formulations, including oral therapies for soft-tissue sarcoma treatment, though no specific named product launches are documented in the available inputs.

Product overview

Novugen Pharma operates in the pharmaceutical/biotechnology sector, specifically focused on the sarcoma drugs market. Based on available source data, the company is developing treatments for soft tissue sarcoma, with an emphasis on oral therapies and innovative drug formulations. No specific named products, modules, or detailed portfolio information is available from the provided sources.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic pharmaceutical products Manufactured generic medicines and pharmaceutical products distributed to healthcare providers and treatment centers. The product range targets cost-sensitive healthcare buyers seeking affordable oral solid-dosage generic alternatives.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Sun Pharmaceutical Industries: World's fourth-largest generic pharma company, manufacturing and distributing a wide generics portfolio globally. Directly comparable in business model as a generic FDF manufacturer-distributor.
• Cipla: Major Indian generic pharma manufacturer and distributor with strong presence in emerging markets and therapeutic categories such as oncology and respiratory. Closely comparable to Novugen's generic pharma manufacturing-distribution thesis.
• Aurobindo Pharma: One of the largest generic pharmaceutical manufacturers globally, producing a broad portfolio of finished dosage forms. Comparable to Novugen as a vertically integrated generic FDF manufacturer with global distribution.
• Strides Pharma Science: India-based generics manufacturer specializing in finished dosage forms with strong emerging-market distribution. Comparable to Novugen as a mid-sized generic FDF manufacturer targeting regulated and emerging markets.
• Dr. Reddy's Laboratories: India-based global generics manufacturer with strong finished dosage form and API capabilities. Directly comparable to Novugen's generic manufacturing and distribution model across emerging and developed markets.

Regional players

• Pharmaniaga: Malaysia's largest pharmaceutical company, manufacturing and distributing generics and supplying the Malaysian public healthcare system. Closest regional peer to Novugen given the shared Malaysian manufacturing base and public-sector distribution.
• Hovid Berhad: Malaysian-based generic pharmaceutical manufacturer with export reach across ASEAN and the Middle East. Comparable to Novugen as a Malaysia-headquartered generic FDF manufacturer serving regional markets.
• Duopharma Biotech: Malaysian-listed pharmaceutical manufacturer focused on generics, OTC, and health supplements with a strong domestic distribution network. Comparable as a Malaysia-based peer combining local manufacturing with broad-channel distribution.

Broad incumbents

• Teva Pharmaceutical Industries: World's largest generic pharmaceutical company with extensive finished dosage form and distribution capabilities. A broad incumbent that defines the pricing and scale benchmark Novugen competes against in global generics.
• Sandoz (Novartis division): Global generic and biosimilar medicines business carved out of Novartis, with broad FDF manufacturing and distribution. A broad incumbent comparable to Novugen's generic FDF focus at much larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/novugen

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novugen Pharma